{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:43:46Z","timestamp":1707385426662},"reference-count":69,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1157\/13093879","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T13:55:09Z","timestamp":1163685309000},"page":"576-584","source":"Crossref","is-referenced-by-count":1,"title":["Resistencias a los antivirales en los virus de las hepatitis B y C"],"prefix":"10.1016","volume":"24","author":[{"given":"Ana","family":"S\u00e1ez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Ag\u00fcero-Balb\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13093879_bib1","first-page":"31","article-title":"Viral dynamics in hepatitis B virus infection","volume":"29","author":"Nowak","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1157\/13093879_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(89)90455-8","article-title":"Mutation rate of the hepadnavirus genome","volume":"170","author":"Girones","year":"1989","journal-title":"Virology"},{"key":"10.1157\/13093879_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-2006-939758","article-title":"Antiviral drug resistance: clinical consequences and molecular aspects","volume":"26","author":"Barthololomeusz","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1157\/13093879_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/jhep.2001.22166","article-title":"Nomenclature for antiviral-resistance human hepatitis B virus mutations in the polymerase region","volume":"33","author":"Stuyver","year":"2001","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/135965350400900203","article-title":"Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations","volume":"9","author":"Barthololomeusz","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1157\/13093879_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/135965350400900522","article-title":"Management of antiviral resistance in patients with chronic hepatitis B","volume":"9","author":"Locarnini","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1157\/13093879_bib7","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1128\/AAC.39.7.1430","article-title":"Mechanism of inhibition of duck hepatitis B virus polymerase by (-)-b-L-2\u2019,3\u2019-dideoxy-3\u2019-thyacytidine","volume":"39","author":"Severini","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13093879_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/gast.2000.8559","article-title":"Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B","volume":"119","author":"Liaw","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1157\/13093879_bib9","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1053\/jhep.2001.25084","article-title":"Extended lamivudine treatment in patients with chronic hepatitis b enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy","volume":"33","author":"Leung","year":"2001","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1440-1746.2004.03428.x","article-title":"Four years of lamivudine treatment in Chinese patients with chronic hepatitis B","volume":"19","author":"Chang","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1157\/13093879_bib11","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","article-title":"The hepatitis B virus polymerase mutation rtV173L is selected during lamivudina therapy and enhances viral replication in vitro","volume":"77","author":"Delaney","year":"2003","journal-title":"J Virol"},{"key":"10.1157\/13093879_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep.510270243","article-title":"Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective","volume":"27","author":"Melegari","year":"1998","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib13","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/S0168-8278(03)00318-0","article-title":"Hepatitis B viral resistance: mechanisms and diagnosis","volume":"39","author":"Locarnini","year":"2003","journal-title":"J Hepatol"},{"key":"10.1157\/13093879_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<270::AID-JMV2>3.0.CO;2-1","article-title":"Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudina therapy in Japanese patients with chronic hepatitis B","volume":"59","author":"Ogata","year":"1999","journal-title":"J Med Virol"},{"key":"10.1157\/13093879_bib15","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/JVI.75.10.4771-4779.2001","article-title":"Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B polymerase resistance to lamivudine (3TC) and emtricitabine (FTC)","volume":"75","author":"Das","year":"2001","journal-title":"J Virol"},{"key":"10.1157\/13093879_bib16","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/368083","article-title":"Prevalence and clinical correlates of YMDD variants during lamivudina therapy for patients with chronic hepatitis B","volume":"36","author":"Lai","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13093879_bib17","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/jhep.2001.27563","article-title":"Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolongad lamivudine therapy","volume":"34","author":"Yuen","year":"2001","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib18","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","article-title":"Resistance to adefovir dipivoxil therapy associated with development of a novel mutation in the HBV polymerase","volume":"125","author":"Angus","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1157\/13093879_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jhep.2003.09.022","article-title":"Selection of hepatitis B virus strain resistant to adefovir in a liver transplantation patient","volume":"39","author":"Villeneuve","year":"2003","journal-title":"J Hepatol"},{"key":"10.1157\/13093879_bib20","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa051214","article-title":"Variant of hepatitis B virus with primary resistance to adefovir","volume":"354","author":"Schildgen","year":"2006","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1157\/13093879_bib21","first-page":"A36","article-title":"Incidence and predictors of emergence of adefovir resistant HBV during four years of adefovir dipivoxil (ADV) therapy for patients with chronic hepatitis B (CHB) (abstract)","volume":"42","author":"Locarnini","year":"2005","journal-title":"J Hepatol"},{"key":"10.1157\/13093879_bib22","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1056\/NEJMoa042957","article-title":"Long-term therapy with adefovir dipivoxil for HbeAg-negative chronic hepatitis B","volume":"352","author":"Hadziyannis","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13093879_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2005.10.018","article-title":"Virologic response and resistance to adefovir in patients with chronic hepatitis B","volume":"44","author":"Fung","year":"2006","journal-title":"J Hepatol"},{"key":"10.1157\/13093879_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2002.34740","article-title":"Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeks","volume":"36","author":"Yang","year":"2002","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib25","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1157\/13093879_bib26","first-page":"A962","article-title":"Entecavir two year resistance update: no resistance observed in nucleoside na\u00efve patients and low frequency resistance emergence in lamivudine refractory patients","volume":"42","author":"Colonno","year":"2005","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1172\/JCI11100","article-title":"The polymerase L528M cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance","volume":"107","author":"Ono","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1157\/13093879_bib28","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/jhep.2002.35070","article-title":"Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant utants of hepadnaviruses","volume":"36","author":"Seigneres","year":"2002","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib29","first-page":"589A","article-title":"Tenofovir rescue for patients with lamivudine resistant HBV infection with suboptimal virologic response to adefovir","volume":"42","author":"Van Boemmel","year":"2005","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/135965350501000612","article-title":"Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir","volume":"10","author":"Sheldon","year":"2005","journal-title":"Antivir Ther"},{"issue":"Suppl 1","key":"10.1157\/13093879_bib31","doi-asserted-by":"crossref","first-page":"89.","DOI":"10.1016\/S0168-8278(02)80309-9","article-title":"Lamivudine-resistant HBV is cross-resistant to L-dT and L-dC in vitro","volume":"36","author":"Delaney","year":"2002","journal-title":"J Hepatol"},{"key":"10.1157\/13093879_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/135965350501000507","article-title":"Cross-resistance testing of next-generation nucleoside and nucleotide analogues against lamivudine- resistant HBV","volume":"10","author":"Yang","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1157\/13093879_bib33","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20723","article-title":"Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir","volume":"41","author":"Brunelle","year":"2005","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/viro.1994.1060","article-title":"Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes","volume":"198","author":"Norder","year":"1994","journal-title":"Virology"},{"key":"10.1157\/13093879_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1099\/0022-1317-81-1-67","article-title":"A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness","volume":"81","author":"Stuyver","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1157\/13093879_bib36","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1099\/0022-1317-83-8-2059","article-title":"Genotype H: A new Amerindian genotype of hepatitis B virus revealed in Central America","volume":"83","author":"Arauz-Ruiz","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1157\/13093879_bib37","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1157\/13066851","article-title":"Hepatitis B virus genotypes identified by a Line Probe Assay (LiPA) among chronic carriers from Spain","volume":"22","author":"Echevarr\u00eda","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13093879_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000074988","article-title":"Classifying hepatitis B virus genotypes","volume":"46","author":"Miyakawa","year":"2003","journal-title":"Intervirology"},{"key":"10.1157\/13093879_bib39","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0016-5085(00)70261-7","article-title":"Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B","volume":"118","author":"Kao","year":"2000","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1157\/13093879_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1386-6532(05)80002-2","article-title":"Detection of hepatitis B virus genotypes and mutants: current status","volume":"34","author":"Niesters","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1157\/13093879_bib41","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.20016","article-title":"Viral features of lamivudine resistant hepatitis B genotypes A and D","volume":"39","author":"Zollner","year":"2004","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0168-8278(01)00283-5","article-title":"Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?","volume":"6","author":"Buti","year":"2002","journal-title":"J Hepatol"},{"key":"10.1157\/13093879_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0016-5085(03)00700-5","article-title":"Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil","volume":"125","author":"Westland","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1157\/13093879_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/s-2002-35697","article-title":"Assesing hepatitis B virus resistance in vitro and molecular mechanisms of nucleoside resistance","volume":"22","author":"Zoulim","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1157\/13093879_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2006-939759","article-title":"In vitro models for studying hepatitis B virus drug resistant","volume":"26","author":"Zoulim","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1157\/13093879_bib46","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S1386-6532(02)00193-2","article-title":"Molecular genotyping of hepatitis B virus","volume":"25","author":"Clarke","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1157\/13093879_bib47","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/JCM.39.5.1972-1974.2001","article-title":"Comparison of sequence analysis and the INNO-LiPA HBV DR line probe assay for detection of lamivudine-resistant hepatitis B virus strains in patients under various clinical conditions","volume":"39","author":"Aberle","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13093879_bib48","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1128\/JCM.40.10.3729-3734.2002","article-title":"Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudina therapy: evaluation of performance of INNO-LiPA HBV DR assay","volume":"40","author":"Lok","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13093879_bib49","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1128\/JCM.44.3.1094-1097.2006","article-title":"Sensitive line probe assay that simultaneously detects mutations conveying resistance to lamivudine and adefovir","volume":"44","author":"Hussain","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13093879_bib50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2004.06.003","article-title":"Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance un HIV-infected individuals","volume":"121","author":"Gallego","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1157\/13093879_bib51","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2006.01.001","article-title":"HBV drug resistance: mechanisms, detection and interpretation","volume":"44","author":"Shaw","year":"2006","journal-title":"J Hepatol"},{"key":"10.1157\/13093879_bib52","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1099\/0022-1317-74-11-2391","article-title":"Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region","volume":"74","author":"Simmonds","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1157\/13093879_bib53","first-page":"103","article-title":"Clinical significance of hepatitis C virus genotypes and quasispecies","volume":"20","author":"Farci","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"Suppl 1","key":"10.1157\/13093879_bib54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.510260721","article-title":"Factors predictive of a beneficial response to therapy of hepatitis C","volume":"26","author":"Davis","year":"1997","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/viro.1997.8493","article-title":"Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein","volume":"230","author":"Gale","year":"1997","journal-title":"Virology"},{"key":"10.1157\/13093879_bib56","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI118025","article-title":"Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b","volume":"96","author":"Enomoto","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1157\/13093879_bib57","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.1128\/MCB.18.9.5208","article-title":"Control of PKR protein kinase by hepatitis C virus non-structural 5a protein: molecular mechanisms of kinase regulation","volume":"18","author":"Gale","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1157\/13093879_bib58","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1099\/vir.0.19513-0","article-title":"Hepatitis C virus NS5A protein interacts with 2\u2019,5\u2019-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner","volume":"85","author":"Taguchi","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1157\/13093879_bib59","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1128\/JVI.75.13.6095-6106.2001","article-title":"Hepatitis C nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response","volume":"75","author":"Polyak","year":"2001","journal-title":"J Virol"},{"key":"10.1157\/13093879_bib60","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/JVI.75.13.6209-6211.2001","article-title":"Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy","volume":"75","author":"Polyak","year":"2001","journal-title":"J Virol"},{"key":"10.1157\/13093879_bib61","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1440-1746.1999.01859.x","article-title":"Relationship between the effect of interferon therapy and the change of hepatitis C virus non-structural 5B gene","volume":"14","author":"Horiike","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1157\/13093879_bib62","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00535-003-1321-6","article-title":"Effect of mutation in the hepatitis C virus nonstructural 5B region on HCV replication","volume":"39","author":"Okura","year":"2004","journal-title":"J Gastroenterol"},{"key":"10.1157\/13093879_bib63","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1440-1746.2005.04024.x","article-title":"Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-alpha plus ribavirin combination therapy","volume":"20","author":"Hamano","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1157\/13093879_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2893.2004.00501.x","article-title":"Polymorphisms of NS5B protein relates to early clearance of hepatitis C virus by interferon plus rivabirin: a pilot study","volume":"11","author":"Kumagai","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1157\/13093879_bib65","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1053\/jhep.2003.50445","article-title":"Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus durin rivabirin monotherapy","volume":"38","author":"Young","year":"2003","journal-title":"Hepatology"},{"key":"10.1157\/13093879_bib66","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/AAC.49.10.4305-4314.2005","article-title":"Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro","volume":"49","author":"Mo","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13093879_bib67","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1572-0241.2003.07469.x","article-title":"Sequence analysis of PePHD within HCV E2 region and correlation with resistance of interferon therapy in japanese patients infected with HCV genotypes 2a and 2b","volume":"98","author":"Saito","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1157\/13093879_bib68","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/JCM.44.3.709-715.2006","article-title":"Analysis of mutations within the 5\u2019 untranslated region, interferon sensitivity region, and PePHD region as a function of response to interferon therapy in hepatitis C virus-infected patients in India","volume":"44","author":"Gupta","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13093879_bib69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jmv.20507","article-title":"Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load","volume":"78","author":"Akuta","year":"2006","journal-title":"J Med Virol"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06738629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X06738629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T09:07:41Z","timestamp":1707383261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X06738629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0213005X06738629"],"URL":"https:\/\/doi.org\/10.1157\/13093879","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}